Close Menu

NEW YORK — Proteomics firm Seer said today that it has closed a $55 million Series D funding round.

The company plans to use the funds to develop and commercialize its Proteograph proteomics platform for research and clinical applications. According to the company the platform allows for proteomics at a scale and speed not possible with existing platforms.

The round was led by life science venture capital fund aMoon with participation from existing and other new investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.

Sponsored by
10x Genomics

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.